Conversely, pathways most enriched in the low ADAM8 expression group, such as inflammatory response and interferon gamma response, suggest a potential role of ADAM8 in the suppression of the immune response in CRC TME. The gene discussed is ADAM8; the disease is colorectal carcinoma.